Redcliffe Labs
PrivateLast Round
Series C
Sep 17, 2024
Est. Valuation
$272.3M
Total Funding Raised
$115M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Redcliffe Labs is a diagnostics and precision medicine company that provides reproductive health testing, rare disease assessments, and cancer gene diagnosis, utilizing in-house technology to deliver comprehensive screening services along with counseling and clinical data management.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, E-commerce, Patient Engagement, Telemedicine
Business Model
B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redcliffe Labs Comparables
Compare Redcliffe Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healthians | 95% | |
| Pathkind Labs | 88% | |
| Medall Healthcare Pvt. Ltd. | 87% |
Redcliffe Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 17, 2024 | ||||
| Private Equity | Jul 6, 2022 | ||||
| Series B | May 6, 2022 | ||||
| Series A | Apr 1, 2021 | ||||
| Seed | Mar 21, 2021 |
Key People
Founding team and executive leadership
Redcliffe Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LetsVenture Online | Seed |
| Spark Growth Ventures | Series B, Series C |
| Impact Fund Denmark | Series C |
| Alkemi Growth Capital | Seed, Series B, Series A |
| Y Combinator | Seed |
| LC Nueva Investment Partners | Series B |
| The Investment Fund for Developing Countries (IFU) | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 20, 2026
Partnered with Roche Diagnostics India to launch a new PCOS blood test.
- Mar 20, 2026
Elecsys AMH Plus blood test for PCOS is now available.
Recent news
Latest coverage and updates
- hiresAug 21, 2026
Redcliffe hired Ramesh Krishnan as Independent Director on Aug 1st '26.
- partners_withAug 14, 2026
Redcliffe partnered with Skyroot on Aug 14th '26.
- integrates_withAug 10, 2026
Redcliffe integrated with ABDM on Aug 10th '26.
- acquiresJul 20, 2026
Redcliffe acquires Sarvodaya Diagnostics Pvt. Ltd..
- expands_facilitiesJul 9, 2026
Redcliffe expanded facilities to Imphāl, India, Southern Asia, Asia on Jul 9th '26.
Redcliffe Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Redcliffe Labs's valuation, stock price, and market status.
Is Redcliffe Labs a public or private company?
Redcliffe Labs is a private company.
What is the current stock price of Redcliffe Labs?
Redcliffe Labs is a private company with no public stock price. No recent secondary market data is available.
How much is Redcliffe Labs worth (valuation)?
Valuation information for Redcliffe Labs is not publicly available.
Can I buy Redcliffe Labs stock?
Redcliffe Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Redcliffe Labs's last funding round?
Redcliffe Labs's most recent funding round was Series C on September 17, 2024.
Who are the main investors in Redcliffe Labs?
Key investors in Redcliffe Labs include Impact Fund Denmark, The Investment Fund for Developing Countries (IFU), Leapfrog Investments.
Will Redcliffe Labs IPO soon?
No public IPO plans have been announced for Redcliffe Labs.
How can I track Redcliffe Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Redcliffe Labs's secondary market activity and sign up for updates.